Sky- Rocket bei QT 5 Inc. (QTFI)

Beiträge: 12
Zugriffe: 853 / Heute: 1
soros:

Sky- Rocket bei QT 5 Inc. (QTFI)

 
06.05.04 18:35
Der Leerverkauf könnte auch noch tiefere Kurse bringen! Split 10:1!
Langsam eindecken, es könnte noch billiger werden!

WKN:A0BM03


Börse NASDAQ OTC BBS  

Aktuell 0,045 USD  

Zeit 06.05.04  18:12  

Diff. Vortag +28,57 %  

Tages-Vol. 25.265,79  

Geh. Stück 545.122  



Geld 0,04  

Brief 0,05  

Zeit 06.05.04  17:19  

Spread 20%  

Geld Stk. 5.000  

Brief Stk. --  



Schluss
Vortag 0,035  

Eröffnung 0,04  

Hoch 0,05  

Tief 0,035  

52W Hoch
soros:

Chart

 
06.05.04 18:38
       Sky- Rocket bei QT 5 Inc. (QTFI) 1491305

Volatil ähnlich wie IVHOE!
     
soros:

last News

 
06.05.04 18:40
QT 5, Inc. Names Edna T. Barris as Vice President of Sales
WESTLAKE VILLAGE, Calif., April 28, 2004 -- QT 5, Inc. , manufacturer, distributor and marketer of biomedical products, has named Edna T. Barris as Vice President of Sales for all Diagnostic Products. Edna joins QT 5, Inc. with 30 years of Biomedical experience, focused on the sales and introduction of rapid diagnostic products for the last 22 years.

With a B.S. degree in Biological Science and Animal Science from Kansas State University, and graduate studies in their School of Veterinary Medicine, Edna began her career in research at Lederle Laboratories, where she is published in numerous fields.

Prior to joining QT 5, Inc., Ms. Barris was a significant part of the sales, sales training, and sales specialists' team for over a decade with Monoclonal Antibodies, Inc., later to merge with Quidel Corporation. She was instrumental in bringing rapid diagnostic testing into the hospital and POL marketplace with the first sandwich assay tests for pregnancy, ovulation, and infectious disease.

"We are excited to have her on board," said Steven H. Reder, QT 5, Inc. president. "Edna is very well respected in the medical diagnostic fields and has a very impressive group of existing relationships that have already proven invaluable."

About QT 5, Inc.

QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: www.qt5inc.com

This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.

CONTACT:  QT 5, Inc.
         Steve Reder, President
         (818) 338-1510
         sreder@qt5inc.com
soros:

QTFI Volatil

 
06.05.04 18:50
Glaube das Teil ist gut zum Zocken:

IVHOE Beispiel:

isht.comdirect.de/charts/small.ewf.chart?hist=10d&sSym=IVHO.NAP

langfristig auch mehr möglich!
joker67:

soros,das ist eine Verbrecherklitsche,von der ich

 
06.05.04 18:55
leider auch noch ein paar shares habe.

Also lngfristig ist da gar nix drin.
Die haben sich zum 5.Mal umfirmiert und treiben ein übles Spiel bei der Ausgabe von Aktien.
Sollten die noch einmal hochgehen ,dann verkloppe ich die und mache drei Kreuze.

joker
soros:

@joker67

 
06.05.04 22:01
Betrüger Buden sind das alle ander OTC, mehr oder weniger! Calypte Bio war auch nicht besser damals, mit Ihren Split von 30:1?

IVHOE ebenfalls!

Trotzdem werden diese Aktien wieder laufen und dann beginnt das selbe Spiel von vorne, verwässern was das Zeug hält. Schaue Dir mal an, wieviele Aktien die meisten Unternehmen heute am Markt haben und im Vergleich dann mal zur Boomzeit! So ist das Spiel halt. Deswegen hat ja fast die gesamte Nasdaq bald einen Reversesplit gemacht.(ironisch gemeint) Es kommen auch wieder andere Zeiten. Angebot und Nachfrage halt.

Kurse von 0,5 ist doch eine lächerliche Marktkapitalisierung!

Was haste noch für Pennystocks an der OTC?
joker67:

Meine Lieblingsaktie mit der ich mittlerweile

 
06.05.04 22:16
3 hypes erlebt habe ist snnw.

Dann habe ich noch ein paar arsw rumliegen die auch eine mega Verwässerung hinter sich haben.

Aber diese Zockerei mit otc Werten ist eben ein Hobby.Manchmal geht es gut und manchmal eben daneben.

qtfi ist leider in die Hose gegangen,aber vielleicht kommen die irgendwann tatsächlich nochmal hoch und dann fliegen sie raus...

greetz joker
NoRiskNoFun:

Jo, ein paar OTC muß man einfach

 
06.05.04 22:34
haben, das ist in *ggg*
Hallo zusammen ;-)
kurspa:

neuer quartalsbericht

 
15.05.04 02:40
sieht böse aus, immer noch höhe verluste

www.sec.gov/Archives/edgar/data/932127/...640/v03322_10qsb.txt
soros:

hm?

 
17.06.04 17:37
QT 5, Inc. Retains Equitilink LLC for Investor Relations
WESTLAKE VILLAGE, Calif., June 2, 2004 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFI), manufacturer, distributor and marketer of biomedical products, today announced that it has retained Equitilink LLC of La Jolla, Calif. as its investor relations firm.

QT 5, Inc. President, Steven H. Reder said, "Our Company's corporate development and growth opportunities are at the point where it is appropriate to retain a sophisticated investor relations firm. We are impressed with Equitilink's broad and proactive relationship with investors who invest in micro cap stocks, and with the extensive and diverse experience of its executives. We believe it is the right firm to advise and assist QT 5, Inc. in our financial communications."

"We believe that QT 5, Inc. has the business plan and the management to succeed at introducing and marketing their full line of diagnostic and first-aid products. We look forward to advising and assisting the company on its financial communications and shareholder relations," said Jim Mahoney, Managing Director of Equitilink LLC. Investors interested in listening to Equitilink's plan for increasing shareholder value for QT 5, Inc. are encouraged to call Equitilink's Investor Service Representatives toll-free at 1-877-788-1940.

About QT 5, Inc.

QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: (www.qt5inc.com).

Safe Harbor

This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.

soros:

(QTFI)wieviel Aktien haben die nun am Markt?

 
17.06.04 17:43
bei otcbb steht 10 Mio Shares und auf einer anderen Seite 20 Mio Shares? Was stimmt denn nun? Haben die nach dem Reversesplit gleich wieder verwässert?

Soros

WKN:A0BM03
kurspa:

ausgeflogen !!!

 
07.07.04 15:19
die büros sind seit tagen leer, nix mehr da !
Es gibt keine neuen Beiträge.


Hot-Stocks-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen
--button_text--